07:57, 29 Sept 2026 AIM & Small Cap
Timeline
Tern
08:31, 16 Sept 2026 AI & Machine Learning
Tern investee Talking Medicines launches Intent to Prescribe tool
Talking Medicines, 23.8%-owned by IoT investor Tern, has added a prescribing-intent feature to its DrugVoice platform through new point-of-care data partnerships.
09:15, 7 Sept 2026 AIM & Small Cap
Tern raises funds via underwritten open offer
The IoT investment company will issue new shares at a 25% discount to fund operations and protect its stakes in portfolio businesses from dilution.
07:50, 3 Aug 2026 AIM & Small Cap
Tern clears outstanding loan facility in full
The tech investment group has repaid the remaining £125,957.26 owed under a loan facility first agreed in 2023, leaving no balance outstanding.
08:13, 28 Jul 2026 Medtech & Diagnostics
Tern boosts Talking Medicines stake, lifts distribution pledge to 70%
The company has invested £117,195 in new convertible loan notes carrying an uplifted principal of £234,389, and separately raised its minimum shareholder distribution commitment from qualifying exits to 70% of net proceeds.
07:38, 23 Jun 2026 Asset Management
Tern posts £5.1m loss as portfolio value falls £4.1m in 2025
The AIM-listed IoT investor recorded a deeper full-year loss as fair value write-downs across its holdings cut net assets to £6.9 million.
10:05, 26 May 2026 · Updated 14:49, 26 May Biotech
Tern shares rocketed after loan note deal
"We are pleased to be able to provide further funding to Talking Medicines which will assist their continued growth trajectory," Jane McCracken said.
10:06, 12 May 2026 · Updated 17:09, 12 May Cybersecurity
Tern shares soar as Device Authority partners with Xalient
Device Authority, which Tern holds 25.3% of, has signed a strategic partnership with Xalient to embed Device Authority's KeyScaler platform into Xalient's managed "as‑a‑service" identity‑led cybersecurity offering for IoT and OT environments.